相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Nanomedicine for brain cancer
Sabina Quader et al.
ADVANCED DRUG DELIVERY REVIEWS (2022)
Gene-based therapies for neurodegenerative diseases
Jichao Sun et al.
NATURE NEUROSCIENCE (2021)
Identification and Validation of ERK5 as a DNA Damage Modulating Drug Target in Glioblastoma
Natasha Carmell et al.
CANCERS (2021)
Nanotechnology as a therapeutic strategy to prevent neuropsychomotor alterations associated with hypercholesterolemia
Matheus Scarpatto Rodrigues et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2021)
Blocking microglial activation of reactive astrocytes is neuroprotective in models of Alzheimer's disease
Jong-Sung Park et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2021)
Nanomedicine for Neurodegenerative Disorders: Focus on Alzheimer's and Parkinson's Diseases
Keelan Jagaran et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Mild magnetic nanoparticle hyperthermia promotes the disaggregation and microglia-mediated clearance of beta-amyloid plaques
Eric Dyne et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2021)
Therapeutic potential of garlic chive-derived vesicle-like nanoparticles in NLRP3 inflammasome-mediated diseases
Baolong Liu et al.
THERANOSTICS (2021)
Delivery across the blood-brain barrier: nanomedicine for glioblastoma multiforme
Lynn Jena et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2020)
Drug delivery across the blood-brain barrier: recent advances in the use of nanocarriers
John J. E. Mulvihill et al.
NANOMEDICINE (2020)
Curcumin's Nanomedicine Formulations for Therapeutic Application in Neurological Diseases
Bahare Salehi et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Predisposition to Alzheimer's and Age-Related Brain Pathologies by PM2.5 Exposure: Perspective on the Roles of Oxidative Stress and TRPM2 Channel
Lu Wang et al.
FRONTIERS IN PHYSIOLOGY (2020)
Nanotheranostic Applications for Detection and Targeting Neurodegenerative Diseases
Ajay Kumar et al.
FRONTIERS IN NEUROSCIENCE (2020)
Mechanisms of NLRP3 priming in inflammaging and age related diseases
Anna Gritsenko et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2020)
Nanotheranostic agents for neurodegenerative diseases
Parasuraman Padmanabhan et al.
EMERGING TOPICS IN LIFE SCIENCES (2020)
Ultrasensitive detection of alpha-synuclein oligomer using a PolyD-glucosamine/gold nanoparticle/carbon-based nanomaterials modified electrochemical immunosensor in human plasma
Dan Tao et al.
MICROCHEMICAL JOURNAL (2020)
Sustained release of bioactive hydrogen by Pd hydride nanoparticles overcomes Alzheimer's disease
Lei Zhang et al.
BIOMATERIALS (2019)
Silymarin and silymarin nanoparticles guard against chronic unpredictable mild stress induced depressive-like behavior in mice: involvement of neurogenesis and NLRP3 inflammasome
Aya Ashraf et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2019)
A new painkiller nanomedicine to bypass the blood-brain barrier and the use of morphine
Jiao Feng et al.
SCIENCE ADVANCES (2019)
Nanoemulsions for Nose-to-Brain Drug Delivery
Maria Cristina Bonferoni et al.
PHARMACEUTICS (2019)
Exosome-like Nanoparticles from Ginger Rhizomes Inhibited NLRP3 Inflammasome Activation
Xingyi Chen et al.
MOLECULAR PHARMACEUTICS (2019)
Inflammaging and Oxidative Stress in Human Diseases: From Molecular Mechanisms to Novel Treatments
Li Zuo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Alzheimer's disease
C. A. Lane et al.
EUROPEAN JOURNAL OF NEUROLOGY (2018)
Metal Ion/Tannic Acid Assembly as a Versatile Photothermal Platform in Engineering Multimodal Nanotheranostics for Advanced Applications
Tao Liu et al.
ACS NANO (2018)
Review on nanoparticles and nanostructured materials: history, sources, toxicity and regulations
Jaison Jeevanandam et al.
BEILSTEIN JOURNAL OF NANOTECHNOLOGY (2018)
Current Trends and Challenges in the Clinical Translation of Nanoparticulate Nanomedicines: Pathways for Translational Development and Commercialization
Susan Hua et al.
FRONTIERS IN PHARMACOLOGY (2018)
Treatment of neurodegenerative disorders through the blood-brain barrier using nanocarriers
N. Poovaiah et al.
NANOSCALE (2018)
Inflammasome signalling in brain function and neurodegenerative disease
Michael T. Heneka et al.
NATURE REVIEWS NEUROSCIENCE (2018)
Nanomedicine: Principles, Properties, and Regulatory Issues
Sara Soares et al.
FRONTIERS IN CHEMISTRY (2018)
Gold nanoparticles - an optical biosensor for RNA quantification or cancer and neurologic disorders diagnosis
Sherif M. Shawky et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2018)
Blood-Brain Delivery Methods Using Nanotechnology
Daniel Mihai Teleanu et al.
PHARMACEUTICS (2018)
NLR members NLRC4 and NLRP3 mediate sterile inflammasome activation in microglia and astrocytes
Leslie Freeman et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
The Ketone Body β-Hydroxybutyrate Does Not Inhibit Synuclein Mediated Inflammasome Activation in Microglia
Vandana Deora et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2017)
Tau-based therapies in neurodegeneration: opportunities and challenges
Chuanzhou Li et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Deletion of the Inflammasome Sensor Aim2 Mitigates A beta Deposition and Microglial Activation but Increases Inflammatory Cytokine Expression in an Alzheimer Disease Mouse Model
Pei-Jung Wu et al.
NEUROIMMUNOMODULATION (2017)
NLRP3 Inflammasome in Neurological Diseases, from Functions to Therapies
Limin Song et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2017)
Soluble phospho-tau from Alzheimer's disease hippocampus drives microglial degeneration
Elisabeth Sanchez-Mejias et al.
ACTA NEUROPATHOLOGICA (2016)
In vitro screening of nanomedicines through the blood brain barrier: A critical review
Juan Aparicio-Blanco et al.
BIOMATERIALS (2016)
AuNPs modified, disposable, ITO based biosensor: Early diagnosis of heat shock protein 70
Munteha Nur Sonuc Karaboga et al.
BIOSENSORS & BIOELECTRONICS (2016)
Targeting specific cells in the brain with nanomedicines for CNS therapies
Fan Zhang et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Activation of phagocytic activity in astrocytes by reduced expression of the inflammasome component ASC and its implication in a mouse model of Alzheimer disease
Julien Couturier et al.
JOURNAL OF NEUROINFLAMMATION (2016)
The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer's disease
Marina Saresella et al.
MOLECULAR NEURODEGENERATION (2016)
Inflammasomes: mechanism of assembly, regulation and signalling
Petr Broz et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Amyloid fibrils are the molecular trigger of inflammation in Parkinson's disease
Adelin Gustot et al.
BIOCHEMICAL JOURNAL (2015)
Neuronal NLRP1 inflammasome activation of Caspase-1 coordinately regulates inflammatory interleukin-1-beta production and axonal degeneration-associated Caspase-6 activation
V. Kaushal et al.
CELL DEATH AND DIFFERENTIATION (2015)
Inflammasome-Induced IL-1β Secretion in Microglia Is Characterized by Delayed Kinetics and Is Only Partially Dependent on Inflammatory Caspases
Saskia M. Burm et al.
JOURNAL OF NEUROSCIENCE (2015)
AIM2 and NLRC4 inflammasomes contribute with ASC to acute brain injury independently of NLRP3
Adam Denes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Activation of MyD88-dependent TLR1/2 signaling by misfolded α-synuclein, a protein linked to neurodegenerative disorders
Stefano G. Daniele et al.
SCIENCE SIGNALING (2015)
Activation of MyD88-dependent TLR1/2 signaling by misfolded α-synuclein, a protein linked to neurodegenerative disorders
Stefano G. Daniele et al.
SCIENCE SIGNALING (2015)
Clinical and Cellular Roles for TDP1 and TOP1 in Modulating Colorectal Cancer Response to Irinotecan
Cornelia Meisenberg et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Topoisomerase-mediated chromosomal break repair: an emerging player in many games
Mohamed E. Ashour et al.
NATURE REVIEWS CANCER (2015)
Autophagy in microglia degrades extracellular β-amyloid fibrils and regulates the NLRP3 inflammasome
Mi-Hyang Cho et al.
AUTOPHAGY (2014)
Are there roles for brain cell senescence in aging and neurodegenerative disorders?
Florence C. C. Tan et al.
BIOGERONTOLOGY (2014)
Nanomedicine and its Application in Treatment of Microglia-mediated Neuroinflammation
N. Baby et al.
CURRENT MEDICINAL CHEMISTRY (2014)
The adaptor ASC has extracellular and 'prionoid' activities that propagate inflammation
Bernardo S. Franklin et al.
NATURE IMMUNOLOGY (2014)
IPAF inflammasome is involved in interleukin-1β production from astrocytes, induced by palmitate; implications for Alzheimer's Disease
Li Liu et al.
NEUROBIOLOGY OF AGING (2014)
Inflammasonnes in neuroinflammation and changes in brain function: a focused review
Gaurav Singhal et al.
FRONTIERS IN NEUROSCIENCE (2014)
Nanomedicine and drug delivery: a mini review
Agha Zeeshan Mirza et al.
INTERNATIONAL NANO LETTERS (2014)
Canonical Nlrp3 Inflammasome Links Systemic Low-Grade Inflammation to Functional Decline in Aging
Yun-Hee Youm et al.
CELL METABOLISM (2013)
Human astrocytes express a novel NLRP2 inflammasome
Julia Minkiewicz et al.
GLIA (2013)
NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice
Michael T. Heneka et al.
NATURE (2013)
A complex secretory program orchestrated by the inflammasome controls paracrine senescence
Juan Carlos Acosta et al.
NATURE CELL BIOLOGY (2013)
CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation
Frederick J. Sheedy et al.
NATURE IMMUNOLOGY (2013)
Differential pathways for interleukin-1β production activated by chromogranin A and amyloid β in microglia
Zhou Wu et al.
NEUROBIOLOGY OF AGING (2013)
Alzheimer's Disease Risk Gene CD33 Inhibits Microglial Uptake of Amyloid Beta
Ana Griciuc et al.
NEURON (2013)
Review: Microglia of the aged brain: primed to be activated and resistant to regulation
D. M. Norden et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2013)
Triggering of Inflammasome by Aggregated α-Synuclein, an Inflammatory Response in Synucleinopathies
Gaia Codolo et al.
PLOS ONE (2013)
Oligomeric amyloid β induces IL-1β processing via production of ROS: implication in Alzheimer's disease
B. Parajuli et al.
CELL DEATH & DISEASE (2013)
Activation and regulation of the inflammasomes
Eicke Latz et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Nanotechnologies: A Strategy to Overcome Blood-Brain Barrier
Giuseppe De Rosa et al.
CURRENT DRUG METABOLISM (2012)
Nanotechnology for neurodegenerative disorders
Francesca Re et al.
MATURITAS (2012)
More Effective Nanomedicines through Particle Design
Jin Wang et al.
SMALL (2011)
Inflammation and Alzheimer's Disease
Young-Jung Lee et al.
ARCHIVES OF PHARMACAL RESEARCH (2010)
Oligomeric amyloid β associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques
Robert M. Koffie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The NALP3 inflammasome is involved in the innate immune response to amyloid-β
Annett Halle et al.
NATURE IMMUNOLOGY (2008)
Dendritic spine abnormalities in amyloid precursor protein transgenic mice demonstrated by gene transfer and intravital multiphoton microscopy
TL Spires et al.
JOURNAL OF NEUROSCIENCE (2005)
Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf
S Mariathasan et al.
NATURE (2004)
Changes in expressions of proinflammatory cytokines IL-1β, TNF-α and IL-6 in the brain of senescence accelerated mouse (SAM) P8
KK Tha et al.
BRAIN RESEARCH (2000)
The inhibitory effects of interleukin-6 on synaptic plasticity in the rat hippocampus are associated with an inhibition of mitogen-activated protein kinase ERK
V Tancredi et al.
JOURNAL OF NEUROCHEMISTRY (2000)
Inflammation and Alzheimer's disease
H Akiyama et al.
NEUROBIOLOGY OF AGING (2000)
分享论文
